On Jul. 22, 2020, a new study led by Albert Einstein College of Medicine and Montefiore Health System confirmed the findings of the large scale British trial of steroid use for COVID-19 patients and advances the research by answering several key questions: Which patients are most likely to benefit from steroid therapy? Could some of them be harmed? Can other formulations of steroids substitute for the agent studied in the British trial? The research was published in the Journal of Hospital Medicine.